SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-136730
Filing Date
2024-05-13
Accepted
2024-05-13 08:05:32
Documents
16
Period of Report
2024-05-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d792227d8k.htm   iXBRL 8-K 25730
2 EX-99.1 d792227dex991.htm EX-99.1 86227
6 GRAPHIC g792227g0510114231448.jpg GRAPHIC 2631
7 GRAPHIC g792227g0510114231840.jpg GRAPHIC 63378
  Complete submission text file 0001193125-24-136730.txt   333871

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bntc-20240513.xsd EX-101.SCH 2886
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bntc-20240513_lab.xml EX-101.LAB 17235
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bntc-20240513_pre.xml EX-101.PRE 10836
19 EXTRACTED XBRL INSTANCE DOCUMENT d792227d8k_htm.xml XML 3485
Mailing Address 3940 TRUST WAY HAYWARD CA 94545
Business Address 3940 TRUST WAY HAYWARD CA 94545 (510) 780-0819
Benitec Biopharma Inc. (Filer) CIK: 0001808898 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39267 | Film No.: 24936962
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)